Εμφάνιση απλής εγγραφής

dc.creatorTsai C., Dimou M., Naef M., Steffen R., Zehetner J., Nakas C.T., Bally L.en
dc.date.accessioned2023-01-31T10:10:48Z
dc.date.available2023-01-31T10:10:48Z
dc.date.issued2022
dc.identifier10.1007/s00464-021-08952-7
dc.identifier.issn09302794
dc.identifier.urihttp://hdl.handle.net/11615/79815
dc.description.abstractBackground: While Roux-en-Y gastric bypass (RYGB) is effective in achieving weight loss and improving obesity-related co-morbidities, insufficient weight loss in the long-term can occur. The goal was to assess whether banded vs. non-banded RYGB reduces the risk of insufficient weight loss at 5-year follow-up. Methods: This is a retrospective single-center cohort study from Switzerland. We assessed the 5-year metabolic trajectories in terms of body weight, body mass index, glucose control, lipid profile and blood pressure of two surgical cohorts undergoing identical RYGB procedures with or without banding using a uniform 6.5 cm silastic Fobi band. Insufficient weight loss was defined as < 50% excess weight loss (EWL) at 5 years. Results: A total of 55 patients receiving banded (Fobi) and 55 patients receiving non-banded (non-Fobi) RYGB were included in the analysis. 5-year follow-up was 91% for both groups. Percentage of EWL at 5 years was 78.11 ± 26.1% and 73.5 ± 27%.3 for the Fobi vs. non-Fobi group (p = 0.368), respectively. Insufficient weight loss (defined as < 50%EWL) at 5 years or last follow-up was significantly higher in the non-Fobi group compared to the Fobi group (19/55 vs. 9/55, respectively, OR = 2.639 (95% CI 1.066, 6.531), p = 0.036). Surrogate markers for cardiometabolic outcomes consistently improved over time, without differences between the groups. During the follow-up period, Fobi-removal was necessary in nine patients (16.3%). Conclusion: Banded-RYGB lowered the odds of insufficient weight loss at 5 years follow-up by approximately 62%. Further research is needed to explore the effect of restriction on eating behaviour and neuroendocrine responses after RYGB. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.en
dc.language.isoenen
dc.sourceSurgical Endoscopyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85122219109&doi=10.1007%2fs00464-021-08952-7&partnerID=40&md5=22b3f5872af4c6b772240d5f14cc22fd
dc.subjecthemoglobin A1cen
dc.subjectsilasticen
dc.subjecttriacylglycerolen
dc.subjectadulten
dc.subjectArticleen
dc.subjectbariatric surgeryen
dc.subjectblood glucose monitoringen
dc.subjectblood pressureen
dc.subjectbody massen
dc.subjectbody weighten
dc.subjectbody weight lossen
dc.subjectcohort analysisen
dc.subjectcomorbidityen
dc.subjectcontrolled studyen
dc.subjectdemographicsen
dc.subjectdiabetes mellitusen
dc.subjectdisease markeren
dc.subjectdyslipidemiaen
dc.subjectelectronic medical recorden
dc.subjectfemaleen
dc.subjectfollow upen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectlipid fingerprintingen
dc.subjectlipid metabolismen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmortalityen
dc.subjectretrospective studyen
dc.subjectRoux-en-Y gastric bypassen
dc.subjectbody weight lossen
dc.subjectfollow upen
dc.subjectgastric bypass surgeryen
dc.subjectmorbid obesityen
dc.subjectphysiologyen
dc.subjectproceduresen
dc.subjectreoperationen
dc.subjecttreatment outcomeen
dc.subjectBody Mass Indexen
dc.subjectCohort Studiesen
dc.subjectFollow-Up Studiesen
dc.subjectGastric Bypassen
dc.subjectHumansen
dc.subjectObesity, Morbiden
dc.subjectReoperationen
dc.subjectRetrospective Studiesen
dc.subjectTreatment Outcomeen
dc.subjectWeight Lossen
dc.subjectSpringeren
dc.titleInsufficient weight loss after banded vs. non-banded primary gastric bypass surgery: insights from an observational 5 year follow-up studyen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής